December 14, 2025 – Each year, around 3,300 men in Israel are diagnosed with prostate cancer—the most common cancer among men. If detected early, the chances of full recovery are high. Breakthrough therapies, developed by or employed at Rambam Health Care Campus (Rambam), are improving life expectancy and quality of life for many patients. The…
February 15, 2024 – As the war continues, more medical volunteers arrive at Rambam Health Care Campus (Rambam) in Haifa, Israel to support the war effort. One such physician is radiation oncologist Dr. Steven Frank from Houston, Texas. Dr. Steven Frank is a tenured professor in radiation oncology and holds the Bessie McGoldrick Professorship in…
June 29, 2023 – Reducing radiation exposure is a welcoming option for prostate cancer patients who usually require 30–40 radiation sessions. Now, Rambam Health Care Campus (Rambam) in Haifa, Israel, offers prostate cancer patients a one-time treatment followed by a few brief follow-up sessions. This novel procedure is safe and has very few side effects. …
June 28, 2022 – Rambam Health Care Campus treated the first-ever prostate cancer patient with innovative alpha-radiation cancer therapy – Alpha DaRT developed by Alpha Tau Medical Ltd. The first patient at Rambam Health Care Campus (Rambam HCC) in Haifa, Israel was treated in a feasibility study with the Alpha DaRT. Alpha DaRT is a…
November 4, 2021 – Three Israeli patients were the first to participate in a study to achieve what has never before been possible: the eradication of inoperable cancer tumors. Researchers at Rambam Health Care Campus created a network-based radiation program using a targeted methodology that has succeeded to eradicate tumors in problematic and difficult to…
